-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOVENT ANNOUNCES IBI3003 (GPRC5D/BCMA/CD3 TRISPECIFIC ANTIBODY) RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FDA FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA

路透·01/27/2026 00:00:00

登录查看新闻详情